BioNTech SE (BNTX)
NASDAQ: BNTX · IEX Real-Time Price · USD
88.49
+0.48 (0.55%)
At close: Apr 23, 2024, 4:00 PM
87.93
-0.56 (-0.63%)
After-hours: Apr 23, 2024, 6:43 PM EDT

BioNTech SE Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Net Income
930.39,43410,29315.2-179.1-48.02-85.65
Depreciation & Amortization
183.4123.375.238.733.921.9810.53
Share-Based Compensation
-714.856.880.532.130.27.645.91
Other Operating Activities
4,9733,963-9,558.5-99.5-83.5-40.4816.65
Operating Cash Flow
5,37113,577889.7-13.5-198.5-58.88-52.56
Operating Cash Flow Growth
-60.44%1426.06%-----
Capital Expenditures
-705.5-362.7-150.6-84.2-71.1-66.45-19.13
Acquisitions
-336.90-20.8-60.6-6.100
Change in Investments
-5,912.1327.4-394.70000
Other Investing Activities
-------33.42
Investing Cash Flow
-6,954.5-35.3-566.1-144.8-77.2-66.45-52.55
Dividends Paid
0-484.300000
Share Issuance / Repurchase
-738.5-875.9160.9753375.4361.730
Debt Issued / Paid
-40.1-59.1-66.71567.93.45-1.64
Other Financing Activities
----14.3---
Financing Cash Flow
-778.6-1,419.394.2894.7383.3365.18-1.64
Exchange Rate Effect
-14.560.164.7-45.30-0.46-24.82
Net Cash Flow
-2,361.712,123417.8736.4107.6239.85-106.75
Free Cash Flow
4,66613,215739.1-97.7-269.6-125.33-71.69
Free Cash Flow Growth
-64.69%1687.94%-----
Free Cash Flow Margin
122.18%76.34%3.89%-20.26%-248.25%-98.24%-116.38%
Free Cash Flow Per Share
19.6354.383.02-0.43-1.19-0.55-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).